Side-by-side comparison of AI visibility scores, market position, and capabilities
SteadyMD built B2B telehealth infrastructure with 600+ clinicians in 50 states (~5M revenue); acquired by DocGo (Oct 2025) to become the clinical backend for digital health platforms.
SteadyMD was founded in 2016 in St. Louis with a mission to build the infrastructure layer that enables healthcare companies to deliver telehealth services without building clinical operations from scratch. The company recognized that the fastest-growing segment of the telehealth market was not direct-to-consumer care but B2B infrastructure — the clinical staffing, licensing, credentialing, compliance, and workflow systems that other healthcare companies need to operate virtual care programs at scale. SteadyMD built this stack as a managed service, enabling digital health companies, health systems, and employers to launch and scale telehealth programs rapidly.\n\nSteadyMD's platform provides healthcare organizations with access to a network of more than 600 clinicians — physicians, nurse practitioners, and physician assistants — who are licensed across all 50 states and available for virtual care delivery. Clients integrate SteadyMD's clinical workforce and telehealth operating system into their own products, using SteadyMD as an outsourced clinical operations partner rather than building in-house clinician networks. This white-label infrastructure model serves clients across consumer health, chronic disease management, occupational health, and behavioral health — wherever organizations need scalable, compliant clinical capacity without the overhead of direct employment.\n\nSteadyMD was acquired by DocGo in October 2025, a publicly traded mobile health and medical transportation company, in a transaction that brings SteadyMD's telehealth infrastructure capabilities under a larger multimodal healthcare services platform. Prior to the acquisition, SteadyMD generated approximately $25 million in annual revenue, demonstrating durable commercial traction in the B2B telehealth infrastructure segment. The DocGo acquisition positions SteadyMD's technology and clinician network as a foundation for DocGo's expansion into virtual care delivery, combining telehealth infrastructure with DocGo's existing in-person mobile health operations.
Mass spectrometry sample prep and data science platform delivering 100x productivity for biopharma protein analysis; $9.1M from Merck Digital Sciences Studio, NIH, and YC at $1.8M revenue.
Andson Biotech is an Atlanta-based healthcare technology company providing mass spectrometry solutions for biopharma and biomanufacturing — offering the DynaCHIP hardware system (a novel mass spectrometry sample preparation platform) and DynaMARK data science module that together deliver up to 100x productivity improvements in protein and biomolecule analysis workflows compared to conventional mass spectrometry setups. Backed by Y Combinator, Merck Digital Sciences Studio, and NIH with $9.1 million raised, Andson achieved $1.8 million in revenue as of December 2024.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.